MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera
Novartis
Novartis
Novartis
AbbVie
Novartis
Emory University
University of California, San Francisco
Barbara Ann Karmanos Cancer Institute
OHSU Knight Cancer Institute
Novartis
Novartis